Business / Corporate Dec 28, 2022
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough
by Kanoko Matsuyama
Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer’s biomarkers in blood tests.
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough
Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer’s biomarkers in blood tests.
Japan medical bodies aim to develop tailored drugs to treat rare diseases
Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon. Sysmex’s diagnostic product that measures amyloid beta in the ...
Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.
Another Crispr first: New treatment wipes out teen's cancer
Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.
China’s reopening poses new challenges for itself and the world
The situation in China is likely to get worse with the ending of the "zero-COVID" policy before it gets better, slowing its economy even more.
Despite unclear effectiveness, kanpō in short supply amid COVID wave
The widespread use and availability of kanpō in Japan has given some people hope that it may work as a viable treatment for the viral disease.
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Shionogi says Japan government to buy 1 million more COVID pill doses
The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.
Ex-Theranos president Ramesh Balwani gets 13-year prison term in fraud case
Balwani and the company's founder, Elizabeth Holmes, had promised to revolutionize the medical industry by using a few drops of blood to complete a wide array of health tests.
Long ICU stays lead to extended misery for many COVID survivors
The mechanical ventilation, anti-inflammatory drugs and other tools of modern medicine that help people beat severe cases of COVID-19 often come with harrowing aftereffects.
Amgen has a contender in the weight-loss drug wars
Amgen’s obesity drug offers a new twist on proven methods to help people lose unwanted pounds.